Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ICL Phosphate Specialty is a global leader in the production of high-purity phosphate-based solutions for the pharmaceutical, food, and industrial sectors. As a core division of ICL Group, the company provides a comprehensive portfolio of pharmaceutical-grade excipients, including calcium phosphates, used extensively in oral solid dosage forms. Their products serve as critical buffering agents, mineral supplements, and stabilizers in various drug formulations and clinical applications. The company is vertically integrated, sourcing phosphate rock from its own mines to ensure a consistent and high-quality supply of specialty ingredients. With a strong focus on regulatory compliance, ICL Phosphate Specialty meets stringent global pharmacopeia standards such as USP, EP, and JP.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ICL Phosphate Specialty.